Literature DB >> 24787338

Myofascial pain syndrome treatments.

Joanne Borg-Stein1, Mary Alexis Iaccarino2.   

Abstract

Myofascial pain syndrome (MPS) is a regional pain disorder caused by taut bands of muscle fibers in skeletal muscles called myofascial trigger points. MPS is a common disorder, often diagnosed and treated by physiatrists. Treatment strategies for MPS include exercises, patient education, and trigger point injection. Pharmacologic interventions are also common, and a variety of analgesics, antiinflammatories, antidepressants, and other medications are used in clinical practice. This review explores the various treatment options for MPS, including those therapies that target myofascial trigger points and common secondary symptoms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Myofascial pain syndrome; Myofascial trigger points; Pharmacotherapy; Regional muscle pain; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24787338     DOI: 10.1016/j.pmr.2014.01.012

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  17 in total

1.  A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management.

Authors:  Sheryl Bourgaize; Genevieve Newton; Dinesh Kumbhare; John Srbely
Journal:  J Can Chiropr Assoc       Date:  2018-04

Review 2.  Management of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal Pain.

Authors:  Salah N El-Tallawy; Rohit Nalamasu; Gehan I Salem; Jo Ann K LeQuang; Joseph V Pergolizzi; Paul J Christo
Journal:  Pain Ther       Date:  2021-02-11

3.  Microstructural Abnormalities Were Found in Brain Gray Matter from Patients with Chronic Myofascial Pain.

Authors:  Peng Xie; Bangyong Qin; Ganjun Song; Yi Zhang; Song Cao; Jin Yu; Jianjiang Wu; Jiang Wang; Tijiang Zhang; Xiaoming Zhang; Tian Yu; Hong Zheng
Journal:  Front Neuroanat       Date:  2016-12-20       Impact factor: 3.856

4.  The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis.

Authors:  Prashanth Panta
Journal:  Indian J Palliat Care       Date:  2017 Apr-Jun

5.  A Case of Trigger-Point Injection-Induced Hypokalemic Paralysis.

Authors:  Paolo K Soriano; Mukul Bhattarai; Carrie N Vogler; Tamer H Hudali
Journal:  Am J Case Rep       Date:  2017-04-26

6.  Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study.

Authors:  Da-Ye Kim; Jae Min Kim
Journal:  Toxins (Basel)       Date:  2018-09-03       Impact factor: 4.546

7.  Comparison of efficacy of corticosteroid injection versus extracorporeal shock wave therapy on inferior trigger points in the quadratus lumborum muscle: a randomized clinical trial.

Authors:  Bina Eftekharsadat; Negar Fasaie; Dina Golalizadeh; Arash Babaei-Ghazani; Fatemeh Jahanjou; Yashar Eslampoor; Neda Dolatkhah
Journal:  BMC Musculoskelet Disord       Date:  2020-10-19       Impact factor: 2.362

8.  Comparison of the Effects of Physiologic Saline Interfascial and Lidocaine Trigger Point Injections in Treatment of Myofascial Pain Syndrome: A Double-Blind Randomized Controlled Trial.

Authors:  Anuphan Tantanatip; Wasa Patisumpitawong; Saridpong Lee
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-03-09

9.  Effectiveness of Botulinum Toxin for Treatment of Symptomatic Pelvic Floor Myofascial Pain in Women: A Systematic Review and Meta-analysis.

Authors:  Melanie R Meister; Allison Brubaker; Siobhan Sutcliffe; Jerry L Lowder
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-01-01       Impact factor: 1.913

10.  Extracorporeal Shock Wave Therapy Versus Trigger Point Injection in the Treatment of Myofascial Pain Syndrome in the Quadratus Lumborum.

Authors:  Jin Oh Hong; Joon Sang Park; Dae Geun Jeon; Wang Hyeon Yoon; Jung Hyun Park
Journal:  Ann Rehabil Med       Date:  2017-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.